Lan bɔt semaglutide (Ozempic/Wegovy) ɛn di sayd ɛfɛkt dɛm we i kin gɛt.

Yu go dɔn yɛri bɔt wan mɛrɛsin we dɛn kɔl Semaglutide dɛn tɛm ya. Bɔku pipul dɛn sabi am ɔnda di brand nem Ozempic ɛn Wegovy. Pan ɔl we dɛn bin mek am fɔs as mɛrɛsin fɔ ɛp fɔ kɔntrol tayp 2 dayabitis , naw bɔku pipul dɛn de yuz am fɔ ɛp fɔ lɛf fɔ it bɔku bɔku it.

So, ilɛk aw dis gud, lɛk ɛvri mɛrɛsin, sɔm sayd ɛfɛkt dɛn de we wi nid fɔ no bɔt. Na dɛn wan ya na di sayd ɛfɛkt dɛn we Semaglutide kin gɛt . I rili impɔtant fɔ ɛnibɔdi we de yuz dis mɛrɛsin ɔ we de tink bɔt fɔ tek am fɔ mek i klia bɔt dɛn sayd ɛfɛkt ya. Dɔn, ivin smɔl tin nɔ go tek am siriɔs, ɛn if siriɔs tin apin, dɛn fɔ no am.

Insay dis atikul, wi go tɔk bɔt ɔltin frɔm smɔl smɔl sayd ɛfɛkt dɛm we kin apin we yu de yuz Semaglutide to rare, siriɔs kɔndishɔn dɛm. Lɛ wi tek wan simpul luk pan wetin mek dɛn kin apin, aw fɔ mɛn dɛn, ɛn ustɛm yu fɔ rili go to dɔktɔ.

Wetin na Semaglutide? Aw i kin wok?

Bifo wi tɔk bɔt di sayd ɛfɛkt dɛm, lɛ wi gɛt smɔl aidia bɔt us kayn drɔg na Semaglutide. i de pan wan klas fכ dכg dεm we dεn kכl GLP-1 rεsεptכr agonist. Dis drɔg de wok di sem we lɛk wan ɔmon we dɛn kɔl GLP-1 we de na wi bɔdi na wi bɔdi. Di GLP-1 ɔmon de ɛp fɔ kɔntrol di shuga we wi gɛt na wi blɔd ɛn di we aw wi want fɔ it.

Na sɔm pan di men tin dɛn we Semaglutide de du:

• I de mek di insulin prodyuz: We di shuga na di blɔd go ɔp, i de ɛp di pankrias fɔ mek insulin. Dis kin kɔntrol di shuga lɛvɛl afta yu dɔn it.
• i de ridyus di prodakshכn fכ glukagon: I de ridyus di prodakshכn fכ glukagon, we na wan כmon we de kכmכt na di pankrεas we de mek di blɔd shuga lεvεl go כp.
• I de slo di dijeshɔn: I de slo di rit we di it de muf frɔm di bɛlɛ to di insay. Dis kin mek yu fil ful, yu nɔ kin want fɔ it, ɛn i kin kɔntrol di shuga we yu blɔd kin go ɔp wantɛm wantɛm afta yu dɔn it.
• I de afɛkt di pat dɛm na di bren we de kɔntrol di apɛtit: I de ridyus angri bay we i de akt pan di apɛtit kɔntrol sɛnta dɛm na di bren.

Fɔ dɛn rizin ya, na dɔktɔ dɛn kin gi Semaglutide mɔ fɔ tin dɛn lɛk:

• Fɔ kɔntrol tayp 2 dayabitis: Kɔntrol di blɔd shuga lɛvɛl wit it ɛn ɛksesaiz.
• Fɔ ridyus di risk fɔ gɛt at sik : Ridyus di risk fɔ gɛt siriɔs sik lɛk at atak ɛn strok pan pipul dɛm we gɛt dayabitis ɛn at sik .
• Fɔ mɛn yu wet we nɔ de mɛn: As ɛp fɔ lɛf fɔ it bɔku bɔku it ɛn fɔ mek yu kɔntinyu fɔ gɛt am, wit di chenj dɛn we yu de chenj yu layf, fɔ pipul dɛn we fat ɔ we gɛt bɔku bɔku bɔdi (at ɔl di wan dɛn we gɛt wan sik we gɛt fɔ du wit dɛn wet lɛk ay blɔd prɛshɔn).
• Fɔ ridyus di risk fɔ gɛt kidni sik: Ridyus di risk fɔ mek di kidni wok wɔs pan sɔm pipul dɛn we gɛt dayabitis ɛn krɛse sik.

Dis na injεkshכn we dεn kin gi כnda di skin wan tεm insay di wik.

Wetin mek i impɔtant fɔ no bɔt di sayd ɛfɛkt dɛn we Semaglutide kin gɛt?

Fɔ bigin fɔ tek nyu mɛrɛsin na big tin fɔ disayd. Yu nid fɔ tink bɔt di bɛnifit dɛn ɛn di bad tin dɛn we go apin to yu. Semaglutide gɛt gud rizɔlt, bɔt fɔ tɔk klia wan bɔt di Semaglutide sayd ifɛkt dɛn we kin kam wit am kin ɛp yu:

• Yu kin no di prɔblɛm kwik kwik wan: We yu no wetin kin apin, i kin izi fɔ no di sayn dɛn we de wɔn yu jɔs afta dɛn dɔn sho.
• Yu kin ebul fɔ kɔntrol wetin yu de op fɔ: We yu no bɔt di kɔmɔn sayd ɛfɛkt dɛm, yu nɔ go fred fɔ no if dɛn apin.
• Yu kin tɔk to yu dɔktɔ fayn fayn wan: We yu no bɔt wetin pɔsibul, yu tɔk to yu dɔktɔ go wok fayn.
• Yu kin disayd fɔ du di bɛst: Dipen pan yu wɛlbɔdi kɔndishɔn, yu kin tɔk to yu dɔktɔ ɛn disayd if di bɛnifit dɛn we yu go gɛt go fayn fɔ yu.

Kɔmɔn Semaglutide sayd ɛfɛkt dɛn

Bɔku pipul dɛn kin gɛt sayd ɛfɛkt we dɛn bigin fɔ yuz Semaglutide, mɔ di wan dɛn we gɛt fɔ du wit di dijestiv sistɛm. Bɔt bɔku tɛm, dɛn tin ya nɔ kin at fɔ du ɔ dɛn kin smɔl. As tɛm de go, dɛn tin ya go stɔp as di bɔdi de ajɔst to di mɛrɛsin. Bɔku tɛm, dɔktɔ dɛn kin inkrisayz di doz smɔl smɔl (taytreshɔn) pas fɔ inkrisayz am ɔl wan tɛm. Dis na tin we kin apin ɔltɛm.Dis na fɔ ridyus di sayd ɛfɛkt dɛm we Semaglutide gɛt.

Di tin we kin mek pɔsin nɔ fil fayn mɔ: Bɛlɛ kin at

Di sayd ɛfɛkt dɛm we dɛn kin ripɔt mɔ bɔt fɔ Semaglutide na we gɛt fɔ du wit bɛlɛ. Dis kin apin bikɔs di mɛrɛsin kin mek di it nɔ digest.

• Nɔs: Dis na di wan we kin apin pas ɔl. I kin apin insay di fɔs wik ɔ afta dɛn dɔn inkrisayz di doz. I kin kɔmɔt frɔm smɔl diskɔmfɔt to smɔl mɔ vɔmit.
• Daya: Na stɔl kin lɔs bɔku tɛm. I impɔtant fɔ drink bɔku wata insay dis tɛm.
• Vɔmit: Pan ɔl we i nɔ kin kɔmɔn lɛk nɔys, sɔntɛnde fɔ vɔmit kin kam wit nɔs.
• Kɔnstipɛshɔn: We yu digest sloslo, dat kin mek i nɔ izi fɔ pas yu stɔl. If yu it tin dɛn we gɛt fayv ɛn drink bɔku wata, dat kin ɛp yu.
• Bɛlɛ de at/nɔ kin fil fayn: Yu kin fil smɔl kramp na yu bɛlɛ, lɛk we yu de rɔl.
• Bloating/flatulence: If yu blo ɛn flat ɔltɛm, dat kin mek yu vɛks smɔl.
• Indigestion/hatburn: We yu fil ful kin fil lɛk at bɔn.
• Bloating: Fɔ fil lɛk se yu bɛlɛ dɔn swel.

Wetin fɔ du fɔ smɔl smɔl prɔblɛm dɛn na yu bɛlɛ lɛk dis? (Advays dɛn):

• Nɔ it bɔku wan tɛm, it smɔl smɔl bɔku tɛm insay di de.
• Nɔ it tin dɛn we gɛt bɔku ɔyl, fat, ɛn shuga as yu ebul.
• It smɔl smɔl.
• Drink bɔku wata ɔl di de.
• Nɔ ledɔm afta yu dɔn it.
• Tɔk to yu dɔktɔ - i kin tɛl yu fɔ chenj smɔl pan yu it ɔ fɔ tek wan simpul mɛrɛsin we yu nɔ de bay.

Ɔda tin dɛn we kin apin to pɔsin

Apat frɔm we di bɛlɛ kin at, ɔda kɔmɔn sayd ɛfɛkt dɛn we Semaglutide kin gɛt na:

• Taya: Na jɔs fɔ fil se yu taya, yu nɔ gɛt trɛnk.
• Ɛd we de at: Smɔl ed kin at.
• Diziz: Na filin fɔ layt ɛn nɔr de balans.

Dis kin fil bad fɔs, bɔt i kin stɔp as tɛm de go.

Rare bɔt signifyant Semaglutide sayd ɛfɛkt dɛn

Pan ɔl we i nɔ kin kɔmɔn lɛk di prɔblɛm dɛn we kin apin we pɔsin de digest, ɔda bad bad tin dɛn de we di wan dɛn we de yuz am fɔ no bɔt:

Riakshכn dεm na di sayt we dεn de injεkshכn

biכs semaglutide na injεkshכn, sכm sכm rεakshכn dεm kin apin na di say we dεn injεkt. Bɔku tɛm, dɛn tin ya nɔ kin siriɔs:

• Rɛdnɛs
• De swɛl
• I de it
• Pen ɔ stiffness
• Lɛk smɔl knot

Dɛn kin ridyus dɛn tin ya bay we yu chenj di say we dɛn injekt (bɛlɛ, shɔl, an) lɛk aw di dɔktɔ tɛl yu.

Chenj na di apɛtit ɔ di sɛns fɔ teist

Sɔm pipul dɛn kin ripɔt se it kin te difrɛn, ɔ dɛn kin fil angri pas aw dɛn kin rili fil ful.

Di ia we de lɔs (alopecia) .

Pan ɔl we i nɔ kin apin ɛn sɔntɛm na fɔ shɔt tɛm, sɔm pipul dɛn dɔn ripɔt se dɛn ia kin tan ɔ lɔs we dɛn de tek semaglutide. Dis kin rili gɛt fɔ du wit we pɔsin de lɔs in wet kwik kwik wan. we yu lכs yu wet kwik kwik wan kin mek bak yu ia lכs fכ sכm tεm (telogen effluvium). Tɔk to yu dɔktɔ if yu gɛt ɛni wan pan dɛn bad bad tin ya we semaglutide kin gɛt .

Siriɔs Semaglutide sayd ɛfɛkt dɛm: If dɛn tin ya apin, go to dɔktɔ wantɛm wantɛm!

Dis na di pat we impɔtant pas ɔl. Pan ɔl we i nɔ kin apin so ɔltɛm, sɔm pan di sayd ɛfɛkt dɛm we Semaglutide kin gɛt kin siriɔs. Dɛn nid fɔ go to dɔktɔ wantɛm wantɛm. If yu si ɛni wan pan di sayn dɛm we de dɔŋ ya, yu fɔ kɔl dɔktɔ ɔr go na ɔspitul ɛn nɔ de te.

Pankriaytis we gɛt sik

Dis na wan siriɔs sayd ɛfɛkt we kin apin. Wach fɔ dɛn sayn ya:

• Bɛlɛ pen bad bad wan: Na pen we kin kam wantɛm wantɛm ɛn we kin kɔmɔt na di bak.
• Pen kin bɔku afta yu dɔn it.
• Nɔs ɛn vɔmit.
• Fiva ɔ kol kol.
• Di at rit we de go ɔp.

If yu bin dɔn gɛt pankrias bifo, nɔ tek semaglutide if yu nɔ tɔk to yu dɔktɔ fayn fayn wan.

Prɔblɛm dɛn we de na di Galblad

Dɛn dɔn se di yus fɔ sɛmaglutayd gɛt fɔ du wit di risk fɔ gɛt gal ston ɔ kɔlesistaytis we de go ɔp. Sayn dɛn:

• Pen na di ɔp rayt say na di bɛlɛ.
• Fiva.
• Di skin ɔ di yay we de yɔlɔ (jaundice).
• Stul dɛn we gɛt kɔlɔ we tan lɛk kle.
• Nɔs ɛn vɔmit.

If yu lɔs yu wet kwik kwik wan, dat kin mek yu gɛt gal ston bak.

Akyu Kidni Injuri

Sɔntɛnde, dɛn dɔn ripɔt se di kidni kin pwɛl wantɛm wantɛm, mɔ pan pipul dɛn we gɛt sik na dɛn kidni ɔ di wan dɛn we nɔ gɛt wata bad bad wan bikɔs dɛn de vɔmit/dayarɛa. Sayn dɛn:

• Di urine we de kɔmɔt na di bɔdi dɔn go dɔŋ.
• Swel (edema) na di leg ɛn ankles.
• Taya ɔ slip.
• I nɔ kin izi fɔ yu fɔ blo.
• Kɔnfyus.
• Vɔmit.

I impɔtant fɔ mek yu gɛt wata, mɔ if yu gɛt prɔblɛm wit yu bɛlɛ.

Siriɔs Alɛji Riakshɔn dɛn

Siriɔs alɛji, we nɔ kin apin so ɔltɛm bɔt kin mek pɔsin in layf de pan denja, kin apin. Go to dɔktɔ wantɛm wantɛm if yu gɛt ɛni wan pan dɛn tin ya:

• Skin rash, it (rash) de it.
• Swel na di fes, di lip, di tɔŋ, di trot (Angioedema).
• I nɔ kin izi fɔ yu fɔ blo ɔ fɔ swɛla.
• We pɔsin de swɛt.
• Diziz ɔ layt ed.

Lɔw blɔd shuga (Hypoglycemia) .

Di risk fɔ mek di blɔd shuga lɛvɛl go dɔŋ bad bad wan we dɛn yuz semaglutide nɔmɔ, nɔ bɔku. Bɔt dis risk kin bɔku we dɛn yuz sɛmaglutayd wit ɔda dayabitis mɛrɛsin dɛn we de mek di blɔd shuga smɔl (e.g., insulin , sulfonylureas ).

Di sayn dɛn we de sho se yu gɛt ay blɔd shuga (we blɔd shuga nɔ bɔku):

• Di bɔdi we de shek shek.
• Swet, fil kol.
• Fɔ wɔri ɔ fɔ nɔ gɛt rɛst.
• Fɔ vɛks.
• Kɔnfyus.
• Di at rit we de go ɔp.
• Diziz we pɔsin kin gɛt.
• Angri.
• Vɔmit.
• Di vishɔn we nɔ klia.
• Di lip ɛn tɔng we de swɛ.
• Ed de at.
• Wik ɔ taya.
• Lɔs fɔ balans.
• Lɔs pan kɔnshɛns ɔr kin gɛt sik (siriɔs kɔndishɔn).

If yu de tek ɔda mɛrɛsin lɛk dɛn wan ya wit semaglutide, i impɔtant fɔ no di sayn dɛm we de sho se yu blɔd shuga nɔ bɔku ɛn wetin fɔ du bɔt am (e.g., it kabɔhaydrɛt we de mek yu blɔd shuga go ɔp kwik kwik wan, lɛk glukɔs tablɛt ɔ frut jus). Yu dɔktɔ kin ajɔst di doz fɔ yu ɔda dayabitis mɛrɛsin dɛn we yu bigin fɔ tek semaglutide.

Di sik we dɛn kɔl dayabitik retinopathy de wɔs

Fɔ pipul dɛm wae gɛt tayp 2 dayabitis ɛn dayabitik retinopathy (wan ay kɔndishɔn), we di blɔd shuga kɔntrol kin bɛtɛ wantɛm wantɛm (as kin apin wit semaglutide), di retinopathy kin wɔs fɔ sɔm tɛm. Tɛl yu dɔktɔ if yu notis ɛni chenj na yu yay, lɛk we yu nɔ de si fayn. I impɔtant fɔ mek pipul dɛn we gɛt dayabitis de chɛk dɛn yay ɔltɛm.

Di at rit we de go ɔp

Sɔm pipul kin kɔntinyu fɔ gɛt inkris hat rit we dɛn de rɛst we dɛn de tek semaglutide. Tɛl yu dɔktɔ if yu fil se yu at de bit kwik kwik wan ivin we yu jɔs tinap.

Pɔtɛnɛshɛl risk fɔ tayroyd C-sɛl kansa (Boxed Warning) .

insay animal stכdi dεm, dεn sho se semaglutide εn di sem kayn GLP-1 dכg dεm de inkrεs di risk fכ tayroyd C-sεl kεnsar (inklud MTC - Medullary Thyroid Carcinoma). Pan ɔl we i nɔ shɔ if dis kin apin to mɔtalman bak, dɛn dɔn ad wan Bɔks Wɔnin bikɔs ɔf dis risk.

• Di tin dɛn we nɔ fɔ du: Nɔ yuz semaglutide if yu ɔ pɔsin na yu famili gɛt MTC, ɔ if yu gɛt wan sik we dɛn kɔl MEN 2 (Multiple Endocrine Neoplasia syndrome type 2).
• Yu fɔ de wach: Tɛl yu dɔktɔ wantɛm wantɛm if yu gɛt wan swɛlin ɔ swel na yu nɛk, yu de ala lawd lawd wan, i nɔ izi fɔ swɛla, ɔ i nɔ izi fɔ blo. Dɛn tin ya kin bi sayn dɛn fɔ gɛt tayroyd kansa.

Bikɔs ɔf dis pɔtnɛshɛl Semaglutide sayd ɛfɛkt , i impɔtant fɔ sheb yu kɔmplit mɛdikal istri ɛn famili mɛdikal istri wit yu dɔktɔ.

Sivεr intestinal prכblεm dεm (ileus/intestinal obstruction) .

Di mɔs kɔmɔn gastrointestinal sayd ɛfɛkt dɛn na bin nɔs ɛn dayarɛa. Bɔt di ripɔt dɛn we dɛn kin gi afta dɛn dɔn mek di makit dɔn ripɔt bak se dɛn gɛt mɔ siriɔs prɔblɛm dɛn, lɛk ileus. Ileus na wan sik we di intestinal dεm de slo dכn εn mek di it εn west nכ muv fayn fayn wan. Di sayn dɛm na we yu bɛlɛ de pen bad bad wan, yu nɔ de gɛt gas ɔ yu stɔl, yu de blo, ɛn yu de vɔmit. Dis na wan rare bɔt siriɔs sayd ɛfɛkt fɔ semaglutide .

Chenj pan di we aw pɔsin de tink ɔ di we aw i de biev fɔ kil insɛf

Jɔs lɛk sɔm ɔda mɛrɛsin dɛn we kin afɛkt di we aw pɔsin kin want fɔ it ɛn wet, dɛn dɔn ripɔt se pipul dɛn we de tek semaglutide kin chenj dɛn maynd, dɛn kin fil bad, ɛn dɛn kin tink ɔr kin biev fɔ kil dɛnsɛf. Yu fɔ wach fɔ ɛni chenj na yu maynd, bihayvya, ɔr tinkin, ɔr pan ɛni ɔda pɔsin we de tek di mɛrɛsin. Tɛl pɔsin we de kia fɔ wɛlbɔdi biznɛs (dɔktɔ) wantɛm wantɛm if yu gɛt nyu pwɛl hat sik, yu de wɔri mɔ ɛn mɔ, ɔ yu de tink bɔt fɔ kil yusɛf.

Tin dɛm wae kin afɛkt Semaglutide sayd ɛfɛkt dɛm

Di we aw Semaglutide sayd ɛfɛkt kin apin ɛn aw dɛn kin tranga kin dipen pan sɔm tin dɛn:

• Doz: Jɛnɛral wan, di mɔ di doz, na di mɔ di risk fɔ gɛt sayd ɛfɛkt. Na dat mek dɛn kin bigin fɔ trit am wit smɔl doz ɛn i kin go ɔp smɔl smɔl.
• Individyual sensitivity: Nɔto ɔlman in bɔdi na di sem. Ɔlman kin biev difrɛn we.
• Ɔda mɛrɛsin dɛn: If yu tek semaglutide wit ɔda mɛrɛsin dɛn (espɛshali di wan dɛn we de afɛkt di blɔd shuga ɔ di dijeshɔn) kin chenj di kayn sayd ɛfɛkt dɛn. Yu fɔ tɛl yu dɔktɔ bɔt ɔl di mɛrɛsin dɛn, sɔpɔtmɛnt dɛn, ɛn di mɛrɛsin dɛn we yu de tek we yu nɔ de bay.
• Di mεdikal kכndyushכn dεm we bin de bifo: Kכndishכn dεm lεk kidni sik, histri fכ pankrεas, gal ston, dayabitik rεtinopathy, εn gastroparesis kin afekt di sef εn sayd ifekt dεm fכ semaglutide.

We yu de wej di gud ɛn bad tin dɛn

Semaglutide na pawaful mɛrɛsin we gɛt pruf fɔ bɛnifit fɔ kɔntrol dayabitis, fɔ mek pɔsin lɔs in wet, ɛn fɔ ridyus di risk fɔ gɛt at sik ɛn kidni sik na sɔm grup dɛn we dɛn dɔn pik. Bɔt lɛk ɔl pawaful drɔgs, semaglutide gɛt di pawa fɔ mek i gɛt sayd ɛfɛkt, frɔm smɔl smɔl tin dɛn we kin mek pɔsin vɛks to prɔblɛm dɛn we nɔ kin apin so ɔltɛm bɔt we kin rili siriɔs.

Di disayd fɔ yuz Semaglutide fɔ bi ɔltɛm wit yu dɔktɔ. I kin ɛp yu:

• Asɛs yu wɛlbɔdi stet ɛn di tin dɛn we kin mek yu gɛt prɔblɛm.
• Ɛksplen di bɛnifit dɛn we yu go gɛt we yu de si yu.
• Evaluate di liklihood fɔ Semaglutide sayd ɛfɛkt ɛn dɛn impak.
• If sayd ɛfɛkt apin, mek plan fɔ wach ɛn manej dɛn.

Fɔ dɔn: Mek disizhɔn we yu no gud gud wan

Semaglutide na big step fɔ go bifo fɔ trit dayabitis ɛn fat pasmak. I klia, bɔt na so bak di sayd ɛfɛkt dɛn we i kin gɛt. Fɔ no di ful rεnj ɔf kɔmɔn, rare, ɛn siriɔs semaglutide sayd ɛfɛkt dɛm impɔtant fɔ yuz dis mɛrɛsin sef ɛn fayn fayn wan.

Nɔ ɛva shem fɔ tɔk to yu dɔktɔ bɔt ɛnitin we de mɔna yu ɔ ɛnitin we yu go gɛt. Opin kɔmyunikeshɔn, strikt adherence to prɛskrib doz ɛn schedule, ɛn ɔwe fɔ di sayn dɛm fɔ siriɔs bad bad tin dɛm na di men tin dɛm fɔ saksesful fɔ manej Semaglutide tritmɛnt. Wit di rayt infɔmeshɔn ɛn gud wok rilayshɔn wit yu mɛdikal tim, yu kin disayd fɔ du gud tin bɔt yu wɛlbɔdi joyn.

( Notis: Dis atikul de gi jenɛral infɔmeshɔn nɔmɔ. Duya, go to pɔsin we sabi du di wok bifo yu disayd fɔ du ɛnitin bɔt mɛrɛsin.)